AEON BIOTECH AS
Operating
Formidle og utvikle helsefremmende og helseforebyggende teknologi og
produkter.
Allmenn legetjeneste, utvikling og salg av helserelatert teknologi og
alt som naturlig er forbundet med dette.
Organization
- CEO
- Chairman of the board
- Years since formation
- 3 years
- since Nov 7, 2023
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100,000
- 1 share class
- Total number of shareholders
- 3
- companies
- Belongs to group of
Financials
- Total operating income 2025
- 11,980
- NOK
- Annual total result 2025
- -59,897
- NOK
- Total equity 2025
- -441,335
- NOK
Last update: Jun 2, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | 80 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
| Chairman | 80 % indirectly | |
JK 1981 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO, Chairman | 80 % indirectly | |
AV | - | 2.32 % indirectly |
KT | - | 1.17 % indirectly |
EB 1981 | - | 1.17 % indirectly |
Last update: Dec 2, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 80,000 | 80 % | |
| Ordinary shares | 10,000 | 10 % | |
| Ordinary shares | 10,000 | 10 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -237,751Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total operating income | 11,980 | 113,020 | 20,507 |
Annual Total Result | -59,897 | -207,199 | -668,669 |
Total assets | 2,103 | 36,301 | 88,093 |
Total liabilities | 443,438 | 167,739 | 12,332 |
Total equity | -441,335 | -131,438 | 75,761 |
P&L
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total operating income | 11,980 | 113,020 | 20,507 |
Total operating costs | 71,877 | 319,967 | 689,175 |
Operating result | -59,897 | -206,948 | -668,669 |
Financial income/costs | 0 | -252 | 0 |
Profit before tax | -59,897 | -207,199 | -668,669 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -59,897 | -207,199 | -668,669 |
Balance overview
| Year | 2025 | 2024 | 2023 |
|---|---|---|---|
Total fixed assets | 0 | 0 | 0 |
Total current assets | 2,103 | 36,301 | 88,093 |
Total assets | 2,103 | 36,301 | 88,093 |
Short term debt | 383,438 | 107,739 | 12,332 |
Long term debt | 0 | 60,000 | 0 |
Total liabilities | 443,438 | 167,739 | 12,332 |
Contributed capital | 494,430 | 744,430 | 744,430 |
Retained earnings | -935,765 | -875,868 | -668,669 |
Total equity | -441,335 | -131,438 | 75,761 |
Total equity and liabilities | 2,103 | 36,301 | 88,093 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises